Total Funding
66
71
Total FundingFunding Round raised
Growth Score
-4 pts
Heat Score
-7 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
138149
TORSKAL is an international biotechnology company, a pioneer of green nanotechnology that develops gold nanoparticles for cancer therapy.
- Anne-Laure Morel: Founder and President
- Maroua Ben Haddada: Material chemist
About the Company
As a pioneer of green nanotechnology in the world, we have developed gold nanoparticles by means of a patented and environmentally friendly process, using medicinal plant extracts from the Indian ocean to treat cancer. Our Nanotheranostics Project (NT1) which treats skin cancers by photothermal therapy is entering phase 1 human clinical trials by
the end of 2021. It will be followed by our second project, Deep Cancer (NT2), which aims to develop new nanotheranostics for the treatment of deep cancers such as prostate and pancreatic cancers.
